Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1996 Oct 1;184(4):1259–1268. doi: 10.1084/jem.184.4.1259

Structural basis for T cell recognition of altered peptide ligands: a single T cell receptor can productively recognize a large continuum of related ligands

PMCID: PMC2192852  PMID: 8879197

Abstract

T cells recognize short linear peptides bound to major histocompatibility complex (MHC)-encoded molecules. Subtle molecular changes in peptide antigens produce altered peptide ligands (APLs), which induce different T cell responses from those induced by the antigenic ligand. A molecular basis for how these slight molecular variations lead to such different consequences for the T cell has not been described. To address this issue, we have made amino acid substitutions at the primary T cell receptor (TCR) contact residue of the murine hemoglobin determinant, Hb(64-76)/I-Ek and produced 12 peptides that interact with the TCR of the T cell clone 3.L2. The 3.L2 T cell responds to these peptides, which vary 1 million-fold in their activity, and enables them to be ranked according to their relative ability to signal through the 3.L2 TCR. Such a ranking reveals that the ability of the 3.L2 T cell to respond to these peptides depends on how well the structure of the side chain at the primary TCR contact site mimics that of the Asn residue present in the antigenic ligand. The reactivity of the 3.L2 T cell also depends on an MHC contact residue that is next to the primary TCR contact residue, suggesting that conformation of the Asn side chain is also important. By using nonnatural amino acids at a TCR contact residue, we have demonstrated that APLs can be rationally designed based on structure. These data are consistent with a model in which the affinity of a peptide-MHC complex for the TCR determines how the T cell will respond.

Full Text

The Full Text of this article is available as a PDF (996.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alam S. M., Travers P. J., Wung J. L., Nasholds W., Redpath S., Jameson S. C., Gascoigne N. R. T-cell-receptor affinity and thymocyte positive selection. Nature. 1996 Jun 13;381(6583):616–620. doi: 10.1038/381616a0. [DOI] [PubMed] [Google Scholar]
  2. Allen P. M. Peptides in positive and negative selection: a delicate balance. Cell. 1994 Feb 25;76(4):593–596. doi: 10.1016/0092-8674(94)90497-9. [DOI] [PubMed] [Google Scholar]
  3. Ashton-Rickardt P. G., Bandeira A., Delaney J. R., Van Kaer L., Pircher H. P., Zinkernagel R. M., Tonegawa S. Evidence for a differential avidity model of T cell selection in the thymus. Cell. 1994 Feb 25;76(4):651–663. doi: 10.1016/0092-8674(94)90505-3. [DOI] [PubMed] [Google Scholar]
  4. Babbitt B. P., Allen P. M., Matsueda G., Haber E., Unanue E. R. Binding of immunogenic peptides to Ia histocompatibility molecules. 1985 Sep 26-Oct 2Nature. 317(6035):359–361. doi: 10.1038/317359a0. [DOI] [PubMed] [Google Scholar]
  5. Bertoletti A., Sette A., Chisari F. V., Penna A., Levrero M., De Carli M., Fiaccadori F., Ferrari C. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature. 1994 Jun 2;369(6479):407–410. doi: 10.1038/369407a0. [DOI] [PubMed] [Google Scholar]
  6. Bjorkman P. J., Saper M. A., Samraoui B., Bennett W. S., Strominger J. L., Wiley D. C. Structure of the human class I histocompatibility antigen, HLA-A2. Nature. 1987 Oct 8;329(6139):506–512. doi: 10.1038/329506a0. [DOI] [PubMed] [Google Scholar]
  7. Bjorkman P. J., Saper M. A., Samraoui B., Bennett W. S., Strominger J. L., Wiley D. C. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature. 1987 Oct 8;329(6139):512–518. doi: 10.1038/329512a0. [DOI] [PubMed] [Google Scholar]
  8. Brown J. H., Jardetzky T. S., Gorga J. C., Stern L. J., Urban R. G., Strominger J. L., Wiley D. C. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature. 1993 Jul 1;364(6432):33–39. doi: 10.1038/364033a0. [DOI] [PubMed] [Google Scholar]
  9. De Magistris M. T., Alexander J., Coggeshall M., Altman A., Gaeta F. C., Grey H. M., Sette A. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell. 1992 Feb 21;68(4):625–634. doi: 10.1016/0092-8674(92)90139-4. [DOI] [PubMed] [Google Scholar]
  10. Evavold B. D., Allen P. M. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science. 1991 May 31;252(5010):1308–1310. doi: 10.1126/science.1833816. [DOI] [PubMed] [Google Scholar]
  11. Evavold B. D., Sloan-Lancaster J., Allen P. M. Antagonism of superantigen-stimulated helper T-cell clones and hybridomas by altered peptide ligand. Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2300–2304. doi: 10.1073/pnas.91.6.2300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Evavold B. D., Sloan-Lancaster J., Hsu B. L., Allen P. M. Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides. J Immunol. 1993 Apr 15;150(8 Pt 1):3131–3140. [PubMed] [Google Scholar]
  13. Evavold B. D., Sloan-Lancaster J., Wilson K. J., Rothbard J. B., Allen P. M. Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity. 1995 Jun;2(6):655–663. doi: 10.1016/1074-7613(95)90010-1. [DOI] [PubMed] [Google Scholar]
  14. Evavold B. D., Williams S. G., Hsu B. L., Buus S., Allen P. M. Complete dissection of the Hb(64-76) determinant using T helper 1, T helper 2 clones, and T cell hybridomas. J Immunol. 1992 Jan 15;148(2):347–353. [PubMed] [Google Scholar]
  15. Fremont D. H., Matsumura M., Stura E. A., Peterson P. A., Wilson I. A. Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. Science. 1992 Aug 14;257(5072):919–927. doi: 10.1126/science.1323877. [DOI] [PubMed] [Google Scholar]
  16. Hogquist K. A., Jameson S. C., Heath W. R., Howard J. L., Bevan M. J., Carbone F. R. T cell receptor antagonist peptides induce positive selection. Cell. 1994 Jan 14;76(1):17–27. doi: 10.1016/0092-8674(94)90169-4. [DOI] [PubMed] [Google Scholar]
  17. Jameson S. C., Carbone F. R., Bevan M. J. Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J Exp Med. 1993 Jun 1;177(6):1541–1550. doi: 10.1084/jem.177.6.1541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Janeway C. A., Jr Ligands for the T-cell receptor: hard times for avidity models. Immunol Today. 1995 May;16(5):223–225. doi: 10.1016/0167-5699(95)80163-4. [DOI] [PubMed] [Google Scholar]
  19. Kersh G. J., Allen P. M. Essential flexibility in the T-cell recognition of antigen. Nature. 1996 Apr 11;380(6574):495–498. doi: 10.1038/380495a0. [DOI] [PubMed] [Google Scholar]
  20. Klenerman P., Rowland-Jones S., McAdam S., Edwards J., Daenke S., Lalloo D., Köppe B., Rosenberg W., Boyd D., Edwards A. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature. 1994 Jun 2;369(6479):403–407. doi: 10.1038/369403a0. [DOI] [PubMed] [Google Scholar]
  21. Lyons D. S., Lieberman S. A., Hampl J., Boniface J. J., Chien Y., Berg L. J., Davis M. M. A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity. 1996 Jul;5(1):53–61. doi: 10.1016/s1074-7613(00)80309-x. [DOI] [PubMed] [Google Scholar]
  22. Matsui K., Boniface J. J., Reay P. A., Schild H., Fazekas de St Groth B., Davis M. M. Low affinity interaction of peptide-MHC complexes with T cell receptors. Science. 1991 Dec 20;254(5039):1788–1791. doi: 10.1126/science.1763329. [DOI] [PubMed] [Google Scholar]
  23. Matsui K., Boniface J. J., Steffner P., Reay P. A., Davis M. M. Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness. Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12862–12866. doi: 10.1073/pnas.91.26.12862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. McKeithan T. W. Kinetic proofreading in T-cell receptor signal transduction. Proc Natl Acad Sci U S A. 1995 May 23;92(11):5042–5046. doi: 10.1073/pnas.92.11.5042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Nicholson L. B., Greer J. M., Sobel R. A., Lees M. B., Kuchroo V. K. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity. 1995 Oct;3(4):397–405. doi: 10.1016/1074-7613(95)90169-8. [DOI] [PubMed] [Google Scholar]
  26. Page D. M., Alexander J., Snoke K., Appella E., Sette A., Hedrick S. M., Grey H. M. Negative selection of CD4+ CD8+ thymocytes by T-cell receptor peptide antagonists. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):4057–4061. doi: 10.1073/pnas.91.9.4057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Pfeiffer C., Stein J., Southwood S., Ketelaar H., Sette A., Bottomly K. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J Exp Med. 1995 Apr 1;181(4):1569–1574. doi: 10.1084/jem.181.4.1569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Rabinowitz J. D., Beeson C., Lyons D. S., Davis M. M., McConnell H. M. Kinetic discrimination in T-cell activation. Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1401–1405. doi: 10.1073/pnas.93.4.1401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Rao A., Faas S. J., Cantor H. Analogs that compete for antigen binding to an arsonate-reactive T-cell clone inhibit the functional response to arsonate. Cell. 1984 Apr;36(4):889–895. doi: 10.1016/0092-8674(84)90038-2. [DOI] [PubMed] [Google Scholar]
  30. Rao A., Ko W. W., Faas S. J., Cantor H. Binding of antigen in the absence of histocompatibility proteins by arsonate-reactive T-cell clones. Cell. 1984 Apr;36(4):879–888. doi: 10.1016/0092-8674(84)90037-0. [DOI] [PubMed] [Google Scholar]
  31. Scannell J. P., Pruess D. L., Demny T. C., Weiss F., Williams T. Antimetabolites produced by microorganisms. II. L-2-amino-4-pentynoic acid. J Antibiot (Tokyo) 1971 Apr;24(4):239–244. doi: 10.7164/antibiotics.24.239. [DOI] [PubMed] [Google Scholar]
  32. Sebzda E., Wallace V. A., Mayer J., Yeung R. S., Mak T. W., Ohashi P. S. Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science. 1994 Mar 18;263(5153):1615–1618. doi: 10.1126/science.8128249. [DOI] [PubMed] [Google Scholar]
  33. Sloan-Lancaster J., Allen P. M. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu Rev Immunol. 1996;14:1–27. doi: 10.1146/annurev.immunol.14.1.1. [DOI] [PubMed] [Google Scholar]
  34. Sloan-Lancaster J., Evavold B. D., Allen P. M. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature. 1993 May 13;363(6425):156–159. doi: 10.1038/363156a0. [DOI] [PubMed] [Google Scholar]
  35. Teale J. M., Klinman N. R. Tolerance as an active process. Nature. 1980 Nov 27;288(5789):385–387. doi: 10.1038/288385a0. [DOI] [PubMed] [Google Scholar]
  36. Townsend A. R., Rothbard J., Gotch F. M., Bahadur G., Wraith D., McMichael A. J. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell. 1986 Mar 28;44(6):959–968. doi: 10.1016/0092-8674(86)90019-x. [DOI] [PubMed] [Google Scholar]
  37. Vidal K., Hsu B. L., Williams C. B., Allen P. M. Endogenous altered peptide ligands can affect peripheral T cell responses. J Exp Med. 1996 Apr 1;183(4):1311–1321. doi: 10.1084/jem.183.4.1311. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES